DiscoverStartupsCambridge Epigenetix
Cambridge Epigenetix company logo
Next generation bisulfite sequencing
View 0 jobs

Cambridge Epigenetix careers

Next generation bisulfite sequencing
Our starting point is TrueMethylTM oxidative bisulfite sequencing (oxBS-Seq), a novel technology that pioneers quantitative, single-base resolution sequencing of the modified bases hydroxymethyl cytosine (5-hmC) and methylcytosine (5-mC). TrueMethyl enables analysis of the DNA methylome with unprecdented accuracy and opens new avenues for basic research, pharmaceutical discovery and diagnostics.

Recent studies have shown that at some sites in the genome the level of 5-hmC can be comparable to the level of 5-mC, emphasizing the importance of identifying these variants accurately. However, traditional bisulfite sequencing cannot discriminate between 5-hmC and 5-mC.

TrueMethyl enables:

Quantitative measurement of 5-hmC and 5-mC in parallel
Single-base resolution methylation and hydroxymethylation analysis
Confirmation of the location of unmethylated cytosines
Jobs

Cambridge Epigenetix hasn't added any jobs yet

Get notified when Cambridge Epigenetix posts new jobs.

See similar jobs
Bobby Yerramilli-Rao
Avatar for Bobby Yerramilli-Rao
Shankar Balasubramanian
Avatar for Shankar Balasubramanian
Valuation

$0

Funded over

1 round

Latest round

Series B (May 2016)

Other Similar Companies Hiring
Noble Biomaterials company logo
Noble BiomaterialsScranton • $64k – $84k • 2 days ago
Arthrex company logo
ArthrexLas Vegas • 6 days ago
Syndax Pharmaceuticals company logo
Syndax PharmaceuticalsNew York City • 1 week ago
Akebia Therapeutics company logo
Akebia TherapeuticsOakland • $178k – $220k • 1 week ago
Wasatch Microfluidics company logo
Wasatch MicrofluidicsIndiana • 1 week ago